Research and analysis

Academics: Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality, 19 June 2020

Paper prepared by academics on COVID-19 diagnosis and mortality.

• From: Scientific Advisory Group for Emergencies
• Published: 14 July 2020

Documents

Academics: Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality, 19 June 2020

https://pubmed.ncbi.nlm.nih.gov/32558877/

Details

Paper published by academics on the association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality. This paper was available for participants to read at SAGE 43 on 23 June 2020, but not considered or discussed in the meeting. As new evidence or data emerges, SAGE updates its advice accordingly.

These documents are released as pre-print publications that have provided the government with rapid evidence during an emergency. These documents have not been peer-reviewed and there is no restriction on authors submitting and publishing this evidence in peer-reviewed journals.

Published 14 July 2020